1. Dell'anna ML, Picardo M. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res. 2006. 19:406–411.
2. Zembowicz A, Mihm MC. Dermal dendritic melanocytic proliferations: an update. Histopathology. 2004. 45:433–451.
Article
3. Harrison-Balestra C, Gugic D, Vincek V. Clinically distinct form of acquired dermal melanocytosis with review of published work. J Dermatol. 2007. 34:178–182.
Article
4. Hamada T, Sakurane HF, Saito T. Behavior of pigment cells on lesions of the pigmented venus with vitiligo. J Dermatol. 1979. 6:143–152.
Article
5. Luo XY, Xu AE, Li JC, Guan CP. Naevus of Ota associated with segmental vitiligo: a case report. J Eur Acad Dermatol Venereol. 2010. 24:611–612.
Article
6. Jimbow K, Chen H, Park JS, Thomas PD. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol. 2001. 144:55–65.
Article
7. Hasse S, Gibbons NC, Rokos H, Marles LK, Schallreuter KU. Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress. J Invest Dermatol. 2004. 122:307–313.
Article
8. Lee AY, Kim NH, Choi WI, Youm YH. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol. 2005. 124:976–983.
Article
9. Eskandani M, Golchai J, Pirooznia N, Hasannia S. Oxidative stress level and tyrosinase activity in vitiligo patients. Indian J Dermatol. 2010. 55:15–19.
Article
10. Shin JH, Kim MJ, Cho S, Whang KK, Hahm JH. A case of giant congenital nevocytic nevus with neurotization and onset of vitiligo. J Eur Acad Dermatol Venereol. 2002. 16:384–386.
Article